Monday, 26 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

CStone Pharmaceuticals Publishes Ayvakit Study Results on Oncologist Website

January 26, 2025
CompanyDeals

Biosion Completes Series B Financing Round Led by Guangfa Xinde Investment

January 26, 2025
CompanyMedical Device

BGI Genomics Receives ANVISA Approval for Colorectal Cancer Detection Kit

January 26, 2025
CompanyDeals

InflaRx and Staidson Amend Deal to Advance Vilobelimab Regulatory Filing in China

January 26, 2025
CompanyDrug

Elpiscience Receives IND Approval for ES014 in China

January 27, 2025
CompanyDeals

Ablaze Pharma and Yonghe Partner for Targeted Radiotherapy Development

January 26, 2025
CompanyDrug

InnoCare Pharma’s Orelabrutinib Placed on Partial Clinical Hold by FDA

January 26, 2025
CompanyDrug

Hainan Poly Pharm Receives FDA Approval for Generic Lincomycin

January 26, 2025
CompanyDrug

Innovent Biologics’ GFH925 Receives Breakthrough Therapy Designation

January 26, 2025
Policy / Regulatory

Sichuan Healthcare Security Administration Announces VBP for Oral Implant Systems

January 26, 2025
CompanyDrug

Junshi Biosciences’ PD-1 Inhibitor Tuoyi Faces FDA Review Delay

January 27, 2025
CompanyDrug

Huadong Medicine’s Lanluma V and X Approved for Use in Hainan

January 27, 2025
1 2 3 4 5 6 … 22 23
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up